This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Serotonergic psychedelic: Difference between revisions
>Unity Decreased diagram size, added lit reference, content. |
>Unity Bolded paper title |
||
| Line 199: | Line 199: | ||
* Béïque, J. C., Imad, M., Mladenovic, L., Gingrich, J. A., & Andrade, R. (2007). '''''Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex.''''' Proceedings of the National Academy of Sciences, 104(23), 9870-9875. | * Béïque, J. C., Imad, M., Mladenovic, L., Gingrich, J. A., & Andrade, R. (2007). '''''Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex.''''' Proceedings of the National Academy of Sciences, 104(23), 9870-9875. | ||
* Winter, J. C., Fiorella, D. J., Timineri, D. M., Filipink, R. A., Helsley, S. E., & Rabin, R. A. (1999). '''''Serotonergic receptor subtypes and hallucinogen-induced stimulus control'''''. Pharmacology Biochemistry and Behavior, 64(2), 283-293. http://doi.org/10.1016/S0091-3057(99)00063-5. | * Winter, J. C., Fiorella, D. J., Timineri, D. M., Filipink, R. A., Helsley, S. E., & Rabin, R. A. (1999). '''''Serotonergic receptor subtypes and hallucinogen-induced stimulus control'''''. Pharmacology Biochemistry and Behavior, 64(2), 283-293. http://doi.org/10.1016/S0091-3057(99)00063-5. | ||
* David E. Nichols and Charles D. Nichols, Serotonin Receptors. Chemical Reviews. 2008. 108 (5), 1614-1641. https://doi.org/10.1021/cr078224o | * David E. Nichols and Charles D. Nichols, '''''Serotonin Receptors'''''. ''Chemical Reviews''. 2008. 108 (5), 1614-1641. https://doi.org/10.1021/cr078224o | ||
* Nichols, D. E. (2004). '''''Hallucinogens.''''' Pharmacology & therapeutics, 101(2), 131-181. | * Nichols, D. E. (2004). '''''Hallucinogens.''''' Pharmacology & therapeutics, 101(2), 131-181. | ||
* Vollenweider, F. X., & Kometer, M. (2010). '''''The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.''''' Nature Publishing Group, 11(9), 642–651. https://doi.org/10.1038/nrn2884 | * Vollenweider, F. X., & Kometer, M. (2010). '''''The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.''''' Nature Publishing Group, 11(9), 642–651. https://doi.org/10.1038/nrn2884 | ||